LTROLAMINE 25

Low platelet counts, known medically as thrombocytopenia, can lead to significant health complications if left untreated. Patients with reduced platelet levels are prone to excessive bruising, prolonged bleeding, and increased risk of infections. In modern medicine, Eltrombopag Olamine, the active ingredient in LITROLAMINE 25 Tablets, has proven to be a highly effective solution for managing thrombocytopenia.

LITROLAMINE 25 contains Eltrombopag Olamine 25 mg, a potent thrombopoietin receptor agonist that stimulates the production of platelets in the bone marrow. This medicine is widely prescribed for adults with conditions such as immune thrombocytopenic purpura (ITP), chronic liver disease-associated thrombocytopenia, and other disorders where platelet counts are abnormally low.

Understanding Thrombocytopenia and Its Risks

What is Thrombocytopenia?

Thrombocytopenia occurs when the platelet count in the blood drops below normal levels. Platelets are crucial for blood clotting and preventing excessive bleeding. Low platelet counts can result in:

• Frequent bruising or purplish spots on the skin

• Nosebleeds or gum bleeding

• Prolonged bleeding after minor cuts or injuries

• Fatigue or general weakness

Severe thrombocytopenia may lead to life-threatening bleeding episodes if not managed promptly.

Causes of Low Platelet Count

Some common causes of thrombocytopenia include:

• Immune Thrombocytopenic Purpura (ITP): An autoimmune condition where the body attacks its own platelets

• Chronic liver disease: Liver dysfunction can reduce platelet production

• Bone marrow disorders: Affect platelet synthesis

• Medications: Certain drugs can suppress platelet formation

• Viral infections: Dengue, hepatitis, or other viral illnesses can reduce platelet counts

Composition of LITROLAMINE 25 Tablets

Eltrombopag Olamine 25 mg

Eltrombopag Olamine is a thrombopoietin receptor agonist. It stimulates the bone marrow to increase platelet production, thereby helping patients maintain safe platelet levels.

Key Features:

• Promotes platelet synthesis in the bone marrow

• Improves clotting function

• Clinically proven in chronic ITP and liver disease-related thrombocytopenia

• Oral administration for easy dosing

How LITROLAMINE 25 Works

Eltrombopag binds to thrombopoietin receptors on megakaryocytes in the bone marrow. This stimulates these cells to produce more platelets. By increasing platelet counts, LITROLAMINE 25 reduces the risk of bleeding, improves clot formation, and enhances overall safety for patients with low platelet disorders.

Uses of LITROLAMINE 25 Tablets

LITROLAMINE 25 is prescribed for:

1. Chronic Immune Thrombocytopenic Purpura (ITP):
   In adults who have not responded to conventional therapies like corticosteroids or immunoglobulins.

2. Thrombocytopenia in Chronic Liver Disease:
   Helps increase platelet counts before medical procedures or surgeries.

3. Other Low Platelet Conditions:
   Used in certain bone marrow disorders or secondary thrombocytopenia under specialist guidance.

Benefits of LITROLAMINE 25

• Increases platelet count effectively

• Reduces risk of spontaneous bleeding and bruising

• Enhances quality of life and reduces hospitalization risk

• Convenient oral administration

• Supports long-term management of chronic thrombocytopenia

Who Should Take LITROLAMINE 25?

LITROLAMINE 25 is recommended for adults with:

• Chronic ITP not responding to conventional treatments

• Liver disease-associated thrombocytopenia needing platelet support

• Persistent low platelet counts due to other medical conditions

It should be used only under the supervision of a healthcare professional.

Dosage and Administration

The dosage of LITROLAMINE 25 is individualized based on platelet levels and response:

• Typically, one 25 mg tablet once daily is prescribed.

• Take on an empty stomach, 1 hour before or 2 hours after meals containing calcium, dairy, or antacids, as these may interfere with absorption.

• Swallow the tablet whole with water.

• Regular monitoring of platelet counts is essential to adjust the dose safely.

Note: Never adjust your dose without consulting your doctor.

Duration of Treatment

• Patients may see platelet improvement within 1–2 weeks.

• Chronic ITP may require long-term therapy.

• Doctors will monitor platelet levels to determine the optimal treatment period.

Possible Side Effects

Like all medications, LITROLAMINE 25 may cause side effects, although most are mild:

Common Side Effects

• Headache

• Nausea

• Fatigue

• Dizziness

Less Common Side Effects

• Abdominal discomfort

• Muscle or joint pain

• Mild skin rashes

Rare but Serious Side Effects

• Liver enzyme abnormalities

• Vision disturbances

• Severe bleeding despite therapy

• Blood clots (thrombosis)

Seek immediate medical attention if serious side effects occur.

Precautions and Warnings

• Avoid use if allergic to Eltrombopag Olamine.

• Patients with liver disease must be closely monitored.

• Blood tests are essential to monitor platelet count and liver function.

• Inform your doctor about other medications or supplements.

Pregnancy and Breastfeeding:

• Safety not established in pregnancy; use only if clearly indicated.

• Breastfeeding mothers should consult their healthcare provider.

Drug Interactions

LITROLAMINE 25 may interact with:

• Antacids or calcium supplements – reduce absorption

• Blood thinners – risk of excessive bleeding

• Certain antiviral or antifungal drugs – may affect liver metabolism

• Other platelet-affecting medications – risk of overproduction

Always inform your doctor about all ongoing medications.

Lifestyle Tips for Patients with Low Platelets

• Eat a balanced diet rich in iron, folate, and vitamin B12

• Avoid alcohol and smoking

• Protect yourself from injuries

• Stay hydrated and active

• Follow medical advice strictly for monitoring platelet counts

Monitoring While on LITROLAMINE 25

• Regular platelet count checks

• Periodic liver function tests

• Monitor for unusual bleeding or clotting

• Report any side effects immediately

Regular monitoring ensures safety and effectiveness of therapy.

Why Choose LITROLAMINE 25?

• Clinically proven Eltrombopag Olamine formulation

• Convenient oral therapy for easy administration

• Reliable platelet count improvement

• Supports safe management of chronic thrombocytopenia

• Manufactured under strict quality standards ensuring safety and efficacy

Conclusion

Low platelet counts can significantly impact a patient’s health, increasing the risk of bleeding and other complications. LITROLAMINE 25 Tablets, containing Eltrombopag Olamine 25 mg, offer a safe and effective solution to increase platelet production, manage chronic ITP, and support liver disease-associated thrombocytopenia.

Frequently Asked Questions (FAQs)

How long does it take for LITROLAMINE 25 to show results?

Patients may see improvement in platelet counts within 1–2 weeks.

Can LITROLAMINE 25 be taken with food?

It is best taken on an empty stomach; avoid calcium-rich meals near dosing time.

Is LITROLAMINE 25 safe for long-term use?

Yes, under medical supervision with regular monitoring.

Can children take LITROLAMINE 25?

It is primarily prescribed for adults. Pediatric use requires specialist supervision.

What should I do if I miss a dose?

Take it as soon as remembered; if it is almost time for the next dose, skip the missed one. Do not double the dose.